On March 5, 2026, Artelo Biosciences, Inc. announced a 1-for-3 reverse stock split, reducing shares from approximately 2.12 million to about 708,258 to improve stock marketability, effective March 10, 2026. Authorized shares decreased from 500 million to 166.67 million.